Analysts Anticipate Encompass Health Corp (NYSE:EHC) Will Announce Earnings of $0.89 Per Share

Equities analysts predict that Encompass Health Corp (NYSE:EHC) will post earnings per share of $0.89 for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Encompass Health’s earnings, with the lowest EPS estimate coming in at $0.86 and the highest estimate coming in at $0.92. Encompass Health reported earnings per share of $0.91 in the same quarter last year, which indicates a negative year-over-year growth rate of 2.2%. The firm is scheduled to issue its next quarterly earnings results after the market closes on Monday, October 28th.

According to Zacks, analysts expect that Encompass Health will report full-year earnings of $3.83 per share for the current financial year, with EPS estimates ranging from $3.76 to $3.87. For the next fiscal year, analysts forecast that the business will post earnings of $3.70 per share, with EPS estimates ranging from $3.61 to $4.00. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that follow Encompass Health.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, July 29th. The company reported $1.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.11. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. Encompass Health had a net margin of 7.01% and a return on equity of 24.10%.

EHC has been the subject of a number of recent research reports. Raymond James lowered their price objective on shares of Encompass Health from $80.00 to $75.00 and set an “outperform” rating for the company in a report on Wednesday, July 31st. Bank of America upgraded shares of Encompass Health to a “buy” rating in a report on Friday, September 6th. Deutsche Bank began coverage on shares of Encompass Health in a report on Tuesday, September 17th. They set a “hold” rating and a $70.00 price target for the company. Finally, BMO Capital Markets began coverage on shares of Encompass Health in a report on Thursday, June 27th. They set an “outperform” rating and a $72.00 price target for the company. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Encompass Health has an average rating of “Buy” and a consensus price target of $74.60.

Shares of EHC traded up $0.18 during mid-day trading on Friday, reaching $66.57. The company’s stock had a trading volume of 12,265 shares, compared to its average volume of 661,023. The stock has a market cap of $6.38 billion, a PE ratio of 18.33, a P/E/G ratio of 1.92 and a beta of 0.84. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 1.87. Encompass Health has a 52 week low of $56.74 and a 52 week high of $76.35. The company’s fifty day moving average price is $62.96 and its two-hundred day moving average price is $62.20.

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were issued a dividend of $0.28 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.27. This represents a $1.12 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date of this dividend was Monday, September 30th. Encompass Health’s dividend payout ratio is currently 30.85%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also: Front-End Load

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.